208
Views
7
CrossRef citations to date
0
Altmetric
Letter

MicroRNA profiling in pediatric acute lymphoblastic leukemia: novel prognostic tools

, , , , , , & show all
Pages 2517-2520 | Received 02 Feb 2012, Accepted 12 Apr 2012, Published online: 22 May 2012

References

  • Schmiegelow K, Forestier E, Hellebostad M, . Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia. Leukemia 2010;24:345–354.
  • Calin GA, Ferracin M, Cimmino A, . A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005;353:1793–1801.
  • Nymark P, Guled M, Borze I, . Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer. Genes Chromosomes Cancer 2011;50:585–597.
  • Borze I, Guled M, Musse S, . MicroRNA microarrays on archive bone marrow core biopsies of leukemias—method validation. Leuk Res 2011;35:188–195.
  • Leoutsakou T, Talieri M, Scorilas A. Expression analysis and prognostic significance of the SRA1 gene, in ovarian cancer. Biochem Biophys Res Commun 2006;344:667–674.
  • Ma HQ, Liang XT, Zhao JJ, . Decreased expression of Neurensin-2 correlates with poor prognosis in hepatocellular carcinoma. World J Gastroenterol 2009;15:4844–4848.
  • Carter SL, Eklund AC, Kohane IS, . A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 2006;38: 1043–1048.
  • Scorilas A, Kyriakopoulou L, Katsaros D, . Cloning of a gene (SR-A1), encoding for a new member of the human Ser/Arg-rich family of pre-mRNA splicing factors: overexpression in aggressive ovarian cancer. Br J Cancer 2001;85:190–198.
  • Nakamura S, Yamashita M, Yokota D, . Development and pharmacologic characterization of deoxybromophospha sugar derivatives with antileukemic activity. Invest New Drugs 2010;28: 381–391.
  • Green MR, Aya-Bonilla C, Gandhi MK, . Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 2011;50:313–326.
  • Ha CH, Jin ZG. Protein kinase D1, a new molecular player in VEGF signaling and angiogenesis. Mol Cells 2009;28:1–5.
  • Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997;18:4–25.
  • Altschmied J, Haendeler J. A new kid on the block: PKD1: a promising target for antiangiogenic therapy? Arterioscler Thromb Vasc Biol 2008;28:1689–1690.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.